The global Biosurgery market gathered revenue around USD 11.0 Billion in 2020 and market is set to grow USD 17.9 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 6.9% during the prediction period 2021 to 2027. Rising focus towards effective blood loss management and growth in the volume of elective surgeries are driving the demand for biosurgery products. Increasing prevalence of lifestyle disorders and chronic diseases and rising geriatric population can be attributed to contribute towards an increase in elective surgical procedures globally. Moreover, increasing incidence of severe traumatic injuries is also driving the demand of biosurgery products as a substitute to alternative suture and ligature-based procedures. Vendors are using organic growth strategies such as product launches and innovations, which has resulted into an increasing availability of advanced products globally.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Biosurgery market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Biosurgery market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Biosurgery market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
North America accounted for the largest share of the biosurgery market in 2020
In 2020, North America accounted for the largest share of the biosurgery market, followed by Europe, Asia Pacific, Latin America, and Middle East & Africa. The large share of this market segment can be characterized by favorable reimbursement policies for biosurgery products, presence of a highly developed healthcare system, the significant number of prominent vendors, the increasing number of healthcare settings, the rising prevalence of traumatic injuries and lifestyle disorders.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Biosurgery Market are:
This market are Johnson & Johnson (US), Baxter International Inc. (US), Medtronic Plc (Ireland), Becton, Dickinson & Co. (US), B. Braun Melsungen AG (Germany), Stryker Corp. (US), Integra Lifesciences Holdings Corp. (US), CSL Ltd. (Australia), Hemostasis LLC. (US), Pfizer Inc. (US), Cyrolife Inc. (US), Zimmer Biomet (US), Kuros Biosciences AG (Switzerland), Orthofix Medical Inc. (US), and Smiths & Nephew Plc. (UK).
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
Global Biosurgery Market, by Product
- Bone Graft Substitutes
- Demineralized bone matrix
- Synthetic Bone Grafts
- Bone Morphogenetic Proteins
- Other Bone-Graft Substitutes
- Soft-tissue attachments
- Synthetic meshes
- Biological meshes
- Hemostatic agents
- Thrombin-based hemostatic agents
- Oxidized regenerated cellulose-based hemostatic agents
- Combination hemostatic agents
- Surgical sealants and adhesives
- Natural/Biological Sealants and Adhesives
- Natural/Biological Sealants and Adhesives, By Type
- Fibrin Sealants
- Collagen-Based Sealants
- Gelatin-Based Sealants
- Albumin-Based Sealants
- Other Natural/Biological Sealants
- Natural/Biological Sealants and Adhesives, By Origin
- Human Blood-Based Sealants and Adhesives
- Animal-Based Sealants and Adhesives
- Synthetic and Semi-Synthetic Sealants and Adhesives
- Peg Hydrogels
- Cyanoacrylate-Based Sealants and Adhesives
- Urethane-Based Sealants and Adhesives
- Other Synthetic and Semi-Synthetic Sealants and Adhesives
- Adhesion Barriers
- Synthetic Adhesion Barriers
- Hyaluronic Acid-Based Adhesion Barriers
- Regenerated Cellulose-Based Adhesion Barriers
- Peg-Based Adhesion Barriers
- Other Synthetic Adhesion Barriers
- Natural Adhesion Barriers
- Collagen & Protein Adhesion Barriers
- Fibrin-Based Adhesion Barriers
- Staple-Line Reinforcement Agents
Global Biosurgery Market, by Application
- Orthopedic Surgery
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Reconstructive Surgery
- Gynecological Surgery
- Urological Surgery
- Thoracic Surgery
- Others
Global Biosurgery Market, by End User
By Geography
North America
Europe
- Germany
- France
- United Kingdom
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of Middle East & Africa
Key Benefits For Stakeholders
- The study provides an in-depth analysis of the Biosurgery market, and the current trends and future estimations to elucidate imminent investment pockets.
- It presents a quantitative analysis of the market from 2021 to 2027 to enable stakeholders to capitalize on the prevailing Biosurgery market opportunities.
- Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
- Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the Biosurgery market.
Request Customization
Get a Sample
Get a Sample
Request Customization